Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi M, Ling Y, Toshikawa C, Hayashida T, Kitagawa Y, Futamura M, Kuwayama T, Nakamura S, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Tsuchida J, Moro K, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Miyoshi Y, Takabe K, Okuda S, Wakai T.
Nagahashi M, et al. Among authors: hayashida t.
Breast Cancer. 2023 Jul;30(4):584-595. doi: 10.1007/s12282-023-01449-2. Epub 2023 Mar 17.
Breast Cancer. 2023.
PMID: 36930419